Director, Business Development Pharma - Basel, Schweiz - Ginkgo Bioworks Inc.

Beschreibung

Our mission is to make biology easier to engineer.

Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe's growing challenges in health, energy, food, materials, and more.

Our bioengineers make use of an in-house automated foundry for designing and building new organisms.


Position Overview:


Key Responsibilities:

-


Market Expansion:

Develop and execute a comprehensive business development strategy to expand Ginkgo's presence in the pharmaceutical and biotech sectors, with a primary focus on the European market.

-


Partnership Development:
Identify, evaluate, and cultivate strategic partnerships with big pharma and smaller biotech companies to drive collaborative research initiatives, licensing agreements and partnerships
-


Brand Establishment:
Collaborate with cross-functional teams to enhance Ginkgo's brand recognition in the European market through effective communication, marketing, and relationship-building
efforts
-
Conferences: Scout and attend key conferences to help achieve Ginkgo's objectives in Europe
-
Negotiation and

Deal Closure:

Lead negotiations for partnership agreements, licensing deals, and other collaborations, ensuring favorable terms and mutually beneficial outcomes for Ginkgo Bioworks.

-


Market Analysis:
Stay abreast of industry trends, competitive landscapes, and emerging opportunities to inform business development strategies and decision-making.
-


Relationship Management:
Foster and maintain strong relationships with key stakeholders, opinion leaders, and decision-makers in the pharmaceutical and biotech industries

Minimum Requirements:

-
Typically 8-10+ YOE plus PhD (or equivalent experience with a Bachelor's), including proven experience growing and developing a team to deliver results
-
Minimum of 4-6 years of experience in business development within the biotech and pharmaceutical sectors, with a proven track record of successfully establishing partnerships and driving business growth
-


Industry Knowledge:
Solid understanding of synthetic biology, biotechnology, and pharmaceutical research. Previous experience in roles such as Biotech Business Development or Pharma Search & Evaluation is highly desirable.
-


Strategic Thinker:
Strong analytical and strategic thinking skills with the ability to identify and capitalize on business opportunities.
-


Communication Skills:

Excellent verbal and written communication skills, with the ability to articulate complex scientific concepts in a clear and compelling manner.

-


Collaborative Spirit:
Proven ability to work collaboratively across interdisciplinary teams and build strong relationships internally and externally.

Preferred Capabilities and Experience:

-
PhD., MD or MBA preferred
-
Deep understanding of drug development across different modalities (RNA, GTx, Biologics, etc.) is a plus
-
Prior experience within a fast-growth company or entrepreneurial environment is a plus.
-
Demonstrated commitment, self-motivation, and drive, and enthusiasm about being a part of Ginkgo's mission
-
Advanced French-language skills and deep knowledge of the French pharmaceutical market is a plus

• What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
• Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15Bplus valuation (Endpoints News)
• Ginkgo Bioworks CEO on scaling up Covid19 testing: 'If we try, we can win' (CNBC)
• Ginkgo raises $70 million to ramp up COVID19 testing for employers, universities (Boston Globe)
• Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
• Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID19 Response (PRNewswire)
• The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
• Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
• Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
• Can This Company Convince You to Love GMOs? (The Atlantic)

We also feel that it's important to point out the obvious here - there's a serious lack of diversity in our industry, and that needs to change.

Our goal is to help drive that change.

Ginkgo is deeply committed to diversity, equity, and inclusion in all of its practices, especially when it comes to growing our team.

Our culture promotes inclusion and embraces how rewarding it is to work with people from all walks of life.

We're developing a powerful biological engineering platform, so we must remain mindful of the many ways our technology can - and will - impact people around the world.

We care about how our platform is used, and having a diverse team to build it gives us the best chance that it's something we'll be proud of as it continues to grow.

Therefore, it'